Landscapes / Companies
Grifols Therapeutics LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 approved
Drugs
3
in active trials · 11 in all
Trials
4 active
18 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 30 Sep 2027Phase 3 trial completes | |||
| Next date | 30 Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency, Alpha 1 Antitrypsin Deficiency | ||||
| Open drug page | |||||
— |
Approved | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma | ||||
| Open drug page | |||||
— |
Approved | 31 Dec 2027Phase 3 trial completes | |||
| Next date | 31 Dec 2027 · Phase 3 trial completes | ||||
| Also tested for | Hypogammaglobulinemia, Bacterial Infections and 4 more | ||||
| Open drug page | |||||
About
- No active trial
- 8 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021